These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. TROAP switches DYRK1 activity to drive hepatocellular carcinoma progression. Li L; Wei JR; Song Y; Fang S; Du Y; Li Z; Zeng TT; Zhu YH; Li Y; Guan XY Cell Death Dis; 2021 Jan; 12(1):125. PubMed ID: 33500384 [TBL] [Abstract][Full Text] [Related]
47. microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer. Yang Q; Jiang W; Zhuang C; Geng Z; Hou C; Huang D; Hu L; Wang X Oncol Rep; 2015 Oct; 34(4):1771-8. PubMed ID: 26239725 [TBL] [Abstract][Full Text] [Related]
48. Galectin 3 regulates HCC cell invasion by RhoA and MLCK activation. Serizawa N; Tian J; Fukada H; Baghy K; Scott F; Chen X; Kiss Z; Olson K; Hsu D; Liu FT; Török NJ; Zhao B; Jiang JX Lab Invest; 2015 Oct; 95(10):1145-56. PubMed ID: 26146960 [TBL] [Abstract][Full Text] [Related]
49. Galectin-9 acts as a prognostic factor with antimetastatic potential in hepatocellular carcinoma. Zhang ZY; Dong JH; Chen YW; Wang XQ; Li CH; Wang J; Wang GQ; Li HL; Wang XD Asian Pac J Cancer Prev; 2012; 13(6):2503-9. PubMed ID: 22938412 [TBL] [Abstract][Full Text] [Related]
50. Induction of apoptosis by Galectin-9 in liver metastatic cancer cells: In vitro study. Tadokoro T; Fujihara S; Chiyo T; Oura K; Samukawa E; Yamana Y; Fujita K; Mimura S; Sakamoto T; Nomura T; Tani J; Yoneyama H; Morishita A; Himoto T; Iwama H; Niki T; Hirashima M; Masaki T Int J Oncol; 2017 Aug; 51(2):607-614. PubMed ID: 28656219 [TBL] [Abstract][Full Text] [Related]
51. Hierarchical and selective roles of galectins in hepatocarcinogenesis, liver fibrosis and inflammation of hepatocellular carcinoma. Bacigalupo ML; Manzi M; Rabinovich GA; Troncoso MF World J Gastroenterol; 2013 Dec; 19(47):8831-49. PubMed ID: 24379606 [TBL] [Abstract][Full Text] [Related]
52. Antitumor Effect of Zinc Acetate in Hepatocellular Carcinoma Cell Lines via the Induction of Apoptosis. Hashimoto R; Himoto T; Yamada M; Mimura S; Fujita K; Tani J; Morishita A; Masaki T J Nutr Sci Vitaminol (Tokyo); 2022; 68(4):303-311. PubMed ID: 36047102 [TBL] [Abstract][Full Text] [Related]
53. Mac-2-binding protein glycan isomer enhances the aggressiveness of hepatocellular carcinoma by activating mTOR signaling. Dolgormaa G; Harimoto N; Ishii N; Yamanaka T; Hagiwara K; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Araki K; Handa T; Yokobori T; Oyama T; Kuwano H; Shirabe K Br J Cancer; 2020 Sep; 123(7):1145-1153. PubMed ID: 32624579 [TBL] [Abstract][Full Text] [Related]
54. Galectin-9 suppresses the proliferation of gastric cancer cells in vitro. Takano J; Morishita A; Fujihara S; Iwama H; Kokado F; Fujikawa K; Fujita K; Chiyo T; Tadokoro T; Sakamoto T; Nomura T; Tani J; Miyoshi H; Yoneyama H; Kobara H; Mori H; Niki T; Hirashima M; Masaki T Oncol Rep; 2016 Feb; 35(2):851-60. PubMed ID: 26717877 [TBL] [Abstract][Full Text] [Related]
55. Effects of galectin-9 on apoptosis, cell cycle and autophagy in human esophageal adenocarcinoma cells. Akashi E; Fujihara S; Morishita A; Tadokoro T; Chiyo T; Fujikawa K; Kobara H; Mori H; Iwama H; Okano K; Suzuki Y; Niki T; Hirashima M; Masaki T Oncol Rep; 2017 Jul; 38(1):506-514. PubMed ID: 28586026 [TBL] [Abstract][Full Text] [Related]
56. Novel roles of galectin-1 in hepatocellular carcinoma cell adhesion, polarization, and in vivo tumor growth. Espelt MV; Croci DO; Bacigalupo ML; Carabias P; Manzi M; Elola MT; Muñoz MC; Dominici FP; Wolfenstein-Todel C; Rabinovich GA; Troncoso MF Hepatology; 2011 Jun; 53(6):2097-106. PubMed ID: 21391228 [TBL] [Abstract][Full Text] [Related]
57. Overexpression of galectin-4 promotes cell growth of hepatocellular carcinoma cells in vitro and in vivo. Chen C; Wang G; Huang X; Dong X; Chen G; Lin M; Cai Z; Zeng Y Int J Clin Exp Pathol; 2017; 10(10):10233-10242. PubMed ID: 31966357 [TBL] [Abstract][Full Text] [Related]
58. Spiropachysine A suppresses hepatocellular carcinoma proliferation by inducing methuosis in vitro and in vivo. Fang Y; Zhong T; Yang L; Luo F; Li Q; Wang D; Li Q; Fan Y; Yang X Phytomedicine; 2022 Jul; 102():154151. PubMed ID: 35584581 [TBL] [Abstract][Full Text] [Related]
59. Novel fusion protein PK5-RL-Gal-3C inhibits hepatocellular carcinoma via anti-angiogenesis and cytotoxicity. Gao X; Jiang P; Wei X; Zhang W; Zheng J; Sun S; Yao H; Liu X; Zhang Q BMC Cancer; 2023 Feb; 23(1):154. PubMed ID: 36793021 [TBL] [Abstract][Full Text] [Related]
60. Antitumor Effect of Galectin-9 on Cell Proliferation and Tumor Growth of Human Duodenal Adenocarcinoma Cells. Kono T; Fujihara S; Oura K; Iwama H; Fujita K; Fujita N; Takuma K; Ono M; Namima D; Yamana H; Chiyo T; Kobayashi K; Kamada H; Kobara H; Ono M; Niki T; Hirashima M; Masaki T Anticancer Res; 2023 Aug; 43(8):3769-3777. PubMed ID: 37500141 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]